AllMeds helps case managers spot high-risk medications, comply with Australian medication standards (e.g., SIRA), and suggests interventions right inside the claims workflow.
You're managing high caseloads, making medication decisions fast, without the clinical expertise to spot dangerous drug combinations. This leads to case managers becoming stressed and leaving the employer.
Most claims teams aren't pharmacists. It's tough to spot risky meds with confidence.
Unmanaged meds can quietly turn short claims into complex, costly cases.
Scanning PDFs and digging through records slows down your workflow.
Guidelines vary by state. Staying compliant takes constant attention.
It's hard to know which claims need action first without clinical red flags.
Medication complexity is the hidden driver of long-tail claims turning into expensive liabilities.
Three in four claimants on high-risk meds at week 12 are still on them at week 52, compounding injury complexity and preventing recovery.
Identifying medication risks requires pharmacist-level knowledge most teams don't have.
From medication list to recommendation in 2 minutes. Case managers use AllMeds at critical intervention points: new claim reviews (week 0-12), ongoing monitoring (weeks 26, 52), prescription changes, and when polypharmacy is suspected. Early identification prevents the 75% medication persistence pattern.
Upload medication documents: pharmacy receipts, dispense histories, Webster packs, IME reports, certificates of capacity. Supports PDFs and images (JPG, PNG).
Proprietary rules engine classifies each medication, identifies interactions and risks based on TGA guidelines, PBS compliance, and opioid prescribing standards
Receive risk report (Low/Moderate/High/Critical) with next steps: refer for independent medical review, continue monitoring in-house, or contact treating doctor
In IMM-managed claims referred through AllMeds
Doctors implement pharmacist recommendations
Per claim on manual medication reviews
Early intervention stops medication-driven blowouts
Stops high-risk medication persistence pattern
Reduction in long-term benzodiazepine use